SEC Filing Summary: AspenBio Pharma, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by AspenBio Pharma, Inc. on August 21, 2009. The registrant is incorporated in Colorado and is based in Castle Rock, CO. The filing reports on a specific regulatory event regarding the company's product development pipeline.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a regulatory update and does not contain financial statements or performance metrics.
Material Changes and Events
- Item 8.01 (Other Events): On August 21, 2009, the company issued a press release stating that its 510(k) filing for the product AppyScore has advanced in FDA review.
- Regulatory Status: The FDA has issued a request for additional information regarding the AppyScore filing.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future outlook, or a discussion of general risks. The primary contingency noted is the requirement to provide additional information to the FDA to proceed with the AppyScore review process.
Key Facts for Investor Verification
- Verify the specific nature of the "additional information" requested by the FDA for the AppyScore 510(k) filing.
- Confirm the expected timeline for resubmitting the requested information and subsequent FDA review milestones.
- Note that the filing metadata in the request referenced "Riot Platforms, Inc.", but the actual document text is for "AspenBio Pharma, Inc."